FABBRINI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 927
EU - Europa 493
AS - Asia 93
AF - Africa 8
SA - Sud America 8
Totale 1.529
Nazione #
US - Stati Uniti d'America 917
IT - Italia 285
SE - Svezia 88
IN - India 39
CN - Cina 31
BG - Bulgaria 24
GB - Regno Unito 21
FR - Francia 16
IE - Irlanda 14
FI - Finlandia 11
SG - Singapore 11
CA - Canada 10
TR - Turchia 10
AR - Argentina 7
PT - Portogallo 7
DE - Germania 6
RO - Romania 6
ES - Italia 4
TG - Togo 4
CZ - Repubblica Ceca 3
UA - Ucraina 3
GH - Ghana 2
NL - Olanda 2
ZA - Sudafrica 2
AL - Albania 1
CL - Cile 1
DK - Danimarca 1
JP - Giappone 1
KZ - Kazakistan 1
SI - Slovenia 1
Totale 1.529
Città #
Fairfield 142
Ashburn 117
Rome 115
Chandler 72
Wilmington 53
Houston 51
Woodbridge 51
Cambridge 47
Seattle 42
San Paolo di Civitate 27
Princeton 26
Sofia 24
Lawrence 23
Millbury 22
New York 20
Milan 19
Ann Arbor 18
Fremont 16
San Diego 15
Beijing 14
Dublin 14
Andover 12
Dearborn 11
Helsinki 9
Putney 9
Boston 8
Plano 8
Florence 7
Toronto 7
Istanbul 5
Boardman 4
Federal 4
Guimarães 4
Lomé 4
Norwalk 4
Romainville 4
Sessa Aurunca 4
Cagliari 3
Izmir 3
Lisbon 3
Madrid 3
Nanjing 3
Palermo 3
Paris 3
Phoenix 3
Singapore 3
Southwark 3
Accra 2
Bari 2
Bremen 2
Catania 2
Cave 2
Ciampino 2
Fontenay-aux-roses 2
Francavilla al Mare 2
Giugliano In Campania 2
Groningen 2
Lanus 2
Liverpool 2
London 2
Naples 2
Newcastle upon Tyne 2
Ottawa 2
Pomezia 2
Rignano Flaminio 2
Santa Lucia di Piave 2
Shanghai 2
Timișoara 2
Vysoka 2
Anguillara 1
Aprilia 1
Barcelona 1
Bologna 1
Boys Town 1
Bühl 1
Campolongo 1
Cardiff 1
Cesena 1
Curuzu Cuatia 1
Des Moines 1
East Riding of Yorkshire 1
Falls Church 1
Fonte Nuova 1
Gavirate 1
Hangzhou 1
Hanover 1
Hefei 1
Koper 1
Ladispoli 1
Lappeenranta 1
Laurel 1
Leawood 1
Les Touches 1
Licata 1
Los Angeles 1
Muizenberg 1
Munich 1
Nanning 1
Napoli 1
Niğde 1
Totale 1.137
Nome #
Salivary alpha-synuclein in the diagnosis of parkinson's disease and progressive supranuclear palsy 126
Quality of life in Parkinson’s disease: Italian validation of the Parkinson’s Disease Questionnaire (PDQ-39-IT) 87
Reliability and validity of the geriatric depression scale in Italian subjects with Parkinson's disease 86
Parkinson's disease among migrants in Europe: estimating the magnitude of an emerging phenomenon 77
Visual hallucinations in Lewy body disease: pathophysiological insights from phenomenology 74
Neuropsychiatric disturbances in atypical Parkinsonian disorders 72
Spread of muscle spasms in hemifacial spasm 70
Salivary caffeine in Parkinson’s disease 69
Altered speech-related cortical network in frontotemporal dementia 66
Re-emergent Tremor in Parkinson's Disease: The Role of the Motor Cortex 65
Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration 64
Cortical mechanisms underlying variability in intermittent theta-burst stimulation-induced plasticity: A TMS-EEG study 62
Risk factors of Parkinson’s disease: Simultaneous assessment, interactions and etiological subtypes 61
Treatment of psychiatric disturbances in hypokinetic movement disorders 59
Writing, reading, and speaking in blepharospasm 57
Tools to assess the quality of life in patients with Parkinson’s disease. A systematic review 52
Parkinsonism is associated with altered primary motor cortex plasticity in frontotemporal dementia–primary progressive aphasia variant 51
Motor Cortical Network Excitability in Parkinson's Disease 50
The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes 49
Effects of cerebellar theta-burst stimulation on arm and neck movement kinematics in patients with focal dystonia 48
Efficacy of occupational therapy interventions on quality of life in patients with Parkinson's disease. A systematic review and meta‐analysis 41
Functional alterations in visual networks underlie differences in the phenomenology of visual hallucinations in Lewy body disease 40
Transcranial alternating current stimulation modulates cortical processing of somatosensory information in a frequency- and time-specific manner 36
A combined panel of salivary biomarkers in de novo Parkinson's Disease 33
Pathophysiological mechanisms and experimental pharmacotherapy for L-Dopa-induced dyskinesia 32
Relationship between risk and protective factors and clinical features of Parkinson's disease 28
The role of frailty in Parkinson’s disease: a cross-sectional study 25
Parkinsonism Is Associated with Altered SMA-Basal Ganglia Structural and Functional Connectivity in Frontotemporal Degeneration 20
The Role of the Motor Cortex in Tremor Suppression in Parkinson's Disease 19
Distal Upper Limb Tremor during Walking in Parkinson's Disease 8
Postural Instability and Risk of Falls in Patients with Parkinson's Disease Treated with Deep Brain Stimulation: A Stabilometric Platform Study 7
Effective connectivity abnormalities in Lewy body disease with visual hallucinations 5
White and gray matter alterations in de novo PD patients: which matter most? 3
Totale 1.642
Categoria #
all - tutte 5.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201954 0 0 0 0 0 0 0 0 0 0 23 31
2019/2020252 22 4 3 11 30 31 36 30 28 26 16 15
2020/2021208 11 16 1 4 23 30 21 16 6 30 20 30
2021/2022377 15 19 22 20 33 18 16 32 28 24 102 48
2022/2023431 59 88 34 27 48 63 8 33 27 13 27 4
2023/2024281 24 30 15 30 17 65 21 49 5 25 0 0
Totale 1.642